全球体外肺模型市场研究报告 - 2023 年至 2030 年产业分析、规模、份额、成长、趋势与预测

预计到 2030 年，全球体外肺模型市场的市场规模将从 2022 年的 336.66 万美元达到近 1,290.54 万美元，2023-2030 年研究期间的CAGR为 18.29%。

体外肺模型是为了在活体之外进行研究、药物开发和测试目的而创建的人类肺的人工表示或模拟。这些模型复製了肺结构和功能的某些方面，以研究呼吸生理学、疾病、药物反应和毒理学。

市场动态

气喘和慢性阻塞性肺病等呼吸系统疾病的流行推动了体外肺模型市场的成长，这需要可靠的研究模型。体外肺模型提供了一个受控环境来研究疾病机制、药物反应和潜在的治疗方法，满足了对有效解决方案不断增长的需求。製药业严重依赖这些模型来加快药物开发和呼吸系统疾病测试，减少对动物测试的依赖并简化药物交互作用和毒性的评估。此外，随着个人化医疗的发展，体外肺模型对于预测个别患者对治疗的反应至关重要，有助于开发标靶治疗。组织工程和 3D 列印等技术进步提高了这些模型的准确性和复杂性，增强了它们与实际肺组织和功能的相似性。此外，减少动物试验的监管压力和吸入毒理学研究的进步进一步推动了体外肺模型的采用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球体外肺模型市场的各个细分市场进行了包容性评估。体外肺模型产业的成长和趋势为这项研究提供了整体方法。

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲体外肺模型市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。体外肺模型市场的主要参与者包括 Epithelix、MATTEK、Lonza、Emulate、AlveoliX AG、Nortis、CN Bio Innovations Ltd、MIMETAS、InSphero、ATTC Global。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：体外肺模型 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按类型分類的市场吸引力分析
  • 市场吸引力分析：依应用分类
  • 按最终用途分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：全球体外肺部模型市场分析：按类型

• 按类型概述
• 历史和预测数据
• 按类型分析
• 2D模型
• 3D模型

第 6 章：全球体外肺模型市场分析：依应用分类

• 概述：按应用
• 历史和预测数据
• 分析：按应用
• 药物发现和毒理学研究
• 生理学研究
• 3D模型开发
• 其他的

第 7 章：全球体外肺模型市场分析：依最终用途分类

• 按最终用途分類的概述
• 历史和预测数据
• 按最终用途分析
• 学术研究机构
• 製药与生物技术公司
• 其他的

第 8 章：全球体外肺模型市场分析：依地理位置

• 区域展望
• 介绍
• 北美销售分析
  • 概览、历史与预测资料销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概览、历史与预测资料销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概览、历史与预测资料销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 东南亚销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概览、历史与预测资料销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概览、历史与预测资料销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 9 章：体外肺模型公司的竞争格局

• 体外肺部模型市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 10 章：公司简介

• 公司股份分析
• 市场集中度
• Epithelix
• 公司简介
• 公司收入
• 产品
• 最近的发展
• MATTEK
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Lonza
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Emulate
• 公司简介
• 公司收入
• 产品
• 最近的发展
• AlveoliX AG
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Nortis
• 公司简介
• 公司收入
• 产品
• 最近的发展
• CN Bio Innovations Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展
• MIMETAS
• 公司简介
• 公司收入
• 产品
• 最近的发展
• InSphero
• 公司简介
• 公司收入
• 产品
• 最近的发展
• ATTC Global
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for In Vitro Lung Model Market is presumed to reach the market size of nearly USD 1290.54 MN by 2030 from USD 336.66 MN in 2022 with a CAGR of 18.29% under the study period 2023 - 2030.

An in vitro lung model is an artificial representation or simulation of the human lung created for research, drug development, and testing purposes outside of a living organism. These models replicate certain aspects of lung structure and function to study respiratory physiology, diseases, drug responses, and toxicology.

MARKET DYNAMICS

The in vitro lung model market growth is fueled by the increasing prevalence of respiratory diseases like asthma and COPD, which necessitates reliable research models. In vitro lung models provide a controlled environment to study disease mechanisms, drug responses, and potential treatments, catering to the rising demand for effective solutions. Pharmaceutical industries heavily rely on these models to expedite drug development and testing for respiratory conditions, reducing reliance on animal testing and streamlining the assessment of drug interactions and toxicity. Additionally, as personalized medicine gains traction, in vitro lung models are vital in predicting individual patient responses to treatments, aiding in the development of targeted therapies. Technological advancements, including tissue engineering and 3D printing, enhance the accuracy and sophistication of these models, augmenting their resemblance to actual lung tissue and function. Moreover, regulatory pressures to reduce animal testing and advancements in inhalation toxicology studies further drive the adoption of in vitro lung models.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of in vitro lung model. The growth and trends of in vitro lung model industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the in vitro lung model market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

• 2D Model
• 3D Model

By Application

• Drug Discovery & Toxicology Studies
• Physiological Research
• 3D Model Development
• Others

By End-Use

• Academic Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the In Vitro Lung Model market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the In Vitro Lung Model market include Epithelix, MATTEK, Lonza, Emulate, AlveoliX AG, Nortis, CN Bio Innovations Ltd, MIMETAS, InSphero, ATTC Global. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . IN VITRO LUNG MODEL - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By End-use
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY TYPE

• 5.1 Overview by Type
• 5.2 Historical and Forecast Data
• 5.3 Analysis by Type
• 5.4 2D Model Historic and Forecast Sales by Regions
• 5.5 3D Model Historic and Forecast Sales by Regions

6 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY APPLICATION

• 6.1 Overview by Application
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Application
• 6.4 Drug Discovery & Toxicology Studies Historic and Forecast Sales by Regions
• 6.5 Physiological Research Historic and Forecast Sales by Regions
• 6.6 3D Model Development Historic and Forecast Sales by Regions
• 6.7 Others Historic and Forecast Sales by Regions

7 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY END-USE

• 7.1 Overview by End-use
• 7.2 Historical and Forecast Data
• 7.3 Analysis by End-use
• 7.4 Academic Research Institutes Historic and Forecast Sales by Regions
• 7.5 Pharmaceutical & Biotechnology Companies Historic and Forecast Sales by Regions
• 7.6 Others Historic and Forecast Sales by Regions

8 . GLOBAL IN VITRO LUNG MODEL MARKET ANALYSIS BY GEOGRAPHY

• 8.1. Regional Outlook
• 8.2. Introduction
• 8.3. North America Sales Analysis
  • 8.3.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.3.2. North America By Segment Sales Analysis
  • 8.3.3. North America By Country Sales Analysis
  • 8.3.4. United State Sales Analysis
  • 8.3.5. Canada Sales Analysis
  • 8.3.6. Mexico Sales Analysis
• 8.4. Europe Sales Analysis
  • 8.4.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.4.2. Europe by Segment Sales Analysis
  • 8.4.3. Europe by Country Sales Analysis
  • 8.4.4. United Kingdom Sales Analysis
  • 8.4.5. France Sales Analysis
  • 8.4.6. Germany Sales Analysis
  • 8.4.7. Italy Sales Analysis
  • 8.4.8. Russia Sales Analysis
  • 8.4.9. Rest Of Europe Sales Analysis
• 8.5. Asia Pacific Sales Analysis
  • 8.5.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.5.2. Asia Pacific by Segment Sales Analysis
  • 8.5.3. Asia Pacific by Country Sales Analysis
  • 8.5.4. China Sales Analysis
  • 8.5.5. India Sales Analysis
  • 8.5.6. Japan Sales Analysis
  • 8.5.7. South Korea Sales Analysis
  • 8.5.8. Australia Sales Analysis
  • 8.5.9. South East Asia Sales Analysis
  • 8.5.10. Rest Of Asia Pacific Sales Analysis
• 8.6. Latin America Sales Analysis
  • 8.6.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.6.2. Latin America by Segment Sales Analysis
  • 8.6.3. Latin America by Country Sales Analysis
  • 8.6.4. Brazil Sales Analysis
  • 8.6.5. Argentina Sales Analysis
  • 8.6.6. Peru Sales Analysis
  • 8.6.7. Chile Sales Analysis
  • 8.6.8. Rest of Latin America Sales Analysis
• 8.7. Middle East & Africa Sales Analysis
  • 8.7.1. Overview, Historic and Forecast Data Sales Analysis
  • 8.7.2. Middle East & Africa by Segment Sales Analysis
  • 8.7.3. Middle East & Africa by Country Sales Analysis
  • 8.7.4. Saudi Arabia Sales Analysis
  • 8.7.5. UAE Sales Analysis
  • 8.7.6. Israel Sales Analysis
  • 8.7.7. South Africa Sales Analysis
  • 8.7.8. Rest Of Middle East And Africa Sales Analysis

9 . COMPETITIVE LANDSCAPE OF THE IN VITRO LUNG MODEL COMPANIES

• 9.1. In Vitro Lung Model Market Competition
• 9.2. Partnership/Collaboration/Agreement
• 9.3. Merger And Acquisitions
• 9.4. New Product Launch
• 9.5. Other Developments

10 . COMPANY PROFILES OF IN VITRO LUNG MODEL INDUSTRY

• 10.1. Company Share Analysis
• 10.2. Market Concentration Rate
• 10.3. Epithelix
  • 10.3.1. Company Overview
  • 10.3.2. Company Revenue
  • 10.3.3. Products
  • 10.3.4. Recent Developments
• 10.4. MATTEK
  • 10.4.1. Company Overview
  • 10.4.2. Company Revenue
  • 10.4.3. Products
  • 10.4.4. Recent Developments
• 10.5. Lonza
  • 10.5.1. Company Overview
  • 10.5.2. Company Revenue
  • 10.5.3. Products
  • 10.5.4. Recent Developments
• 10.6. Emulate
  • 10.6.1. Company Overview
  • 10.6.2. Company Revenue
  • 10.6.3. Products
  • 10.6.4. Recent Developments
• 10.7. AlveoliX AG
  • 10.7.1. Company Overview
  • 10.7.2. Company Revenue
  • 10.7.3. Products
  • 10.7.4. Recent Developments
• 10.8. Nortis
  • 10.8.1. Company Overview
  • 10.8.2. Company Revenue
  • 10.8.3. Products
  • 10.8.4. Recent Developments
• 10.9. CN Bio Innovations Ltd
  • 10.9.1. Company Overview
  • 10.9.2. Company Revenue
  • 10.9.3. Products
  • 10.9.4. Recent Developments
• 10.10. MIMETAS
  • 10.10.1. Company Overview
  • 10.10.2. Company Revenue
  • 10.10.3. Products
  • 10.10.4. Recent Developments
• 10.11. InSphero
  • 10.11.1. Company Overview
  • 10.11.2. Company Revenue
  • 10.11.3. Products
  • 10.11.4. Recent Developments
• 10.12. ATTC Global
  • 10.12.1. Company Overview
  • 10.12.2. Company Revenue
  • 10.12.3. Products
  • 10.12.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Type (USD MN)
• 2D Model Market Sales by Geography (USD MN)
• 3D Model Market Sales by Geography (USD MN)
• Analysis Market by Application (USD MN)
• Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
• Physiological Research Market Sales by Geography (USD MN)
• 3D Model Development Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis by End-use (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global In Vitro Lung Model Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• South East Asia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of In Vitro Lung Model Report
• Market Research Process
• Market Research Methodology
• Global In Vitro Lung Model Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Type
• Market Attractiveness Analysis by Application
• Market Attractiveness Analysis by End-use
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Type (USD MN)
• 2D Model Market Sales by Geography (USD MN)
• 3D Model Market Sales by Geography (USD MN)
• Global Market Analysis by Application (USD MN)
• Drug Discovery & Toxicology Studies Market Sales by Geography (USD MN)
• Physiological Research Market Sales by Geography (USD MN)
• 3D Model Development Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by End-use (USD MN)
• Academic Research Institutes Market Sales by Geography (USD MN)
• Pharmaceutical & Biotechnology Companies Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Sales (USD MN)
• North America Market Sales (USD MN)
• Europe Market Sales (USD MN)
• Asia Pacific Market Sales (USD MN)
• Latin America Market Sales (USD MN)
• Middle East & Africa Market Sales (USD MN)
• Recent Development in Industry
• Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.